Provided by Tiger Fintech (Singapore) Pte. Ltd.

iTeos Therapeutics

10.11
+0.01500.15%
Post-market: 10.09-0.0200-0.20%17:42 EDT
Volume:1.06M
Turnover:10.68M
Market Cap:446.57M
PE:-3.27
High:10.11
Open:10.10
Low:10.08
Close:10.10
Loading ...
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Correspondence

Form CORRESP - Correspondence
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 15, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2023

Major Issues Report

8-K - Current report
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]